Governance of food safety in China's pre-made dishes industry: legal reforms, policy strategies, and international perspectives. [PDF]
Tang S, Yang Y, Li Z.
europepmc +1 more source
Pharmaceutical access in Brazil: challenges and opportunities. [PDF]
Ruas CM +5 more
europepmc +1 more source
"Hold the retractor, that's it?" - A retrospective longitudinal evaluation-study of the surgical and the elective tertial in the practical year. [PDF]
Junga A +6 more
europepmc +1 more source
Assessing progress of road safety legislation globally: criteria, methodology and evolution 2015-2023. [PDF]
Murphy E, Luo F, Auert J.
europepmc +1 more source
Transforming trade for vaccine equity: Policy gaps and barriers. [PDF]
Pepperrell T +3 more
europepmc +1 more source
Disparities in Access to Cystic Fibrosis Therapy Across Countries. [PDF]
Karadag B.
europepmc +1 more source
Policies to promote affordability and access across the life cycle of costly new drugs.
Kruja K +5 more
europepmc +1 more source
Related searches:
Compulsory Licensing of Patents
Pharmaceutical Patent Analyst, 2022Compulsory licensing (CL) is a mechanism made by the government to provide balance between the monopoly right holders and the third person with public interest by ensuring the ease availability of the patented products at reasonable rate. This paper discusses the background criteria for getting CL in India as per the Indian Patent Act, 1970 starting ...
Narayanasamy Kumutha +2 more
openaire +2 more sources
Thailand and the Compulsory Licensing of Efavirenz
New England Journal of Medicine, 2007In November 2006, Thailand's Ministry of Public Health issued a compulsory license for efavirenz, which permits the Thai government to import generic efavirenz from India. Dr.
openaire +2 more sources
Optimal Patents with Compulsory Licensing
Journal of Political Economy, 1982This paper examines the use of compulsory lincensing as a policy to combat the monopoly problem associated with the patent system. It introduces the notion of an optimal patent--one where the patent life and the licensing royalty rate are both determined optimally.
openaire +1 more source

